Russell Swerdlow
Director, Alzheimer's Disease Research Center · University of Kansas School of Medicine
Credentials: · · · ·
History
- Present
Alzheimer's Disease Research Center · University of Kansas School of Medicine
- Present
Neurodegenerative Disorders Program · University of Kansas School of Medicine
York University
- 1987–1991
- 1983–1987
Research
Systematic review or meta-analysis · Nature Genetics · 2019 · 2,420 citations
Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing
Review · Nature Reviews Drug Discovery · 2020 · 829 citations
Nature Genetics · 2017 · 798 citations
57 papers · 1 as a resident
16 papers · 1 as a resident
- JB
15 papers
13 papers · 13 as a resident
11 papers
11 papers
10 papers · 4 as a resident
9 papers
Grants
- 2025–2031
Mitochondrial Energetic Failures in Men and Women Across Trajectories of Alzheimer Disease
National Institute on Aging · U01
PI · $2.5M · University of Texas Hlth Sci Ctr Houston
- 2021–2031
University of Kansas Alzheimer's Disease Research Center (KU ADRC)
National Institute on Aging · P30
Contact PI · $20.8M · University of Kansas Medical Center
- 2026–2031
Kansas Successful Aging and Resilience COBRE (K-SARC)
National Institute of General Medical Sciences · P20
PI · $2.6M · University of Kansas Medical Center
- 2025–2030
Mitochondria-Nuclear Communication via Lactylation in Alzheimer’s Disease
National Institute on Aging · R01
PI · $1.1M · University of Kansas Medical Center
Clinical trials
- 2017–2021
S-Equol in Alzheimer's Disease 2 Trial
Principal investigator · Completed · Phase 1, Phase 2
Russell Swerdlow
- 2015–2018
Trial of Oxaloacetate in Alzheimer's Disease (TOAD)
Principal investigator · Completed · Phase 1
Russell Swerdlow
- 2014–2016
S-Equol in Alzheimer's Disease (SEAD) Trial
Principal investigator · Completed · Phase 1
Russell Swerdlow, MD
- 2014